Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1980-11-07
1986-02-18
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514505, A61K 3726
Patent
active
045713910
ABSTRACT:
Chromium(III) tris-acetylacetonate, a coordinatively saturated, stable chromium(III) compound provides a dietary chromium supplement for humans and lower animals and is a useful hypoglycemic pharmaceutical agent for treating diabetes, especially when used in conjunction with insulin therapy.
REFERENCES:
patent: 3914410 (1975-10-01), Godfrey
patent: 3925433 (1975-12-01), Abdel-Monem
Schwartz et al--"Archives of Biochemistry and Biophysics", vol. 85, pp. 292-295 (1959).
Mertz--"Nutrition Reviews, vol. 33, No. 5, May 1975, pp. 129-135.
The Merck Index, Ninth Edition, 1976, pp. 659 and 1223, Merck & Co., Inc., Rahway, N.J., U.S.A.
Jeejeebhoy et al., "Chromium Deficiency, Glucose Intolerance, and Neuropathy Reversed by Chromium Supplementation, in a Patient Receiving Long-Term Total Parenteral Nutrition", Am. J. Clin. Nut., vol. 30 (1977) pp. 531-538.
Freund et al., "Chromium Deficiency During Total Parenteral Nutrition", J. Am. Med. Assoc., vol. 241, No. 5 (1979) pp. 496-498.
Anderson Mark M.
Riley Dennis P.
Rotruck John T.
Goldstein Steven J.
Guttag Eric W.
The Procter & Gamble & Company
Waddell Frederick E.
Witte Richard C.
LandOfFree
Chromium acetylacetonate as a dietary supplement and pharmaceuti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chromium acetylacetonate as a dietary supplement and pharmaceuti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chromium acetylacetonate as a dietary supplement and pharmaceuti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1550986